Increased EGFR activity is associated with numerous malignant tumors, including esophageal cancers, glioblastoma, anal cancers, epithelial cancers of the head and neck, breast cancer, and lung cancers [12,13,14,15,16], especially non-small cell lung cancer (NSCLC). Here, EGFR is linked to non-small cell lung carcinoma.